Evidence map›Paper›PMID 24586148›Full record

ArticlePLoS pathogens2014

Gem-induced cytoskeleton remodeling increases cellular migration of HTLV-1-infected cells, formation of infected-to-target T-cell conjugates and viral transmission.

Sébastien A Chevalier, Jocelyn Turpin, Anne Cachat, Philippe V Afonso, Antoine Gessain, John N Brady, Cynthia A Pise-Masison, Renaud Mahieux

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Host Subcellular Organelles: Targets of Viral Manipulation.International journal of molecular sciences · 2024
    Review
  5. Upregulation of Neuropilin-1 Inhibits HTLV-1 Infection.Pathogens (Basel, Switzerland) · 2023
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 2 countries.

Sébastien A ChevalierEquipe Oncogenèse Rétrovirale, Equipe labellisée "Ligue Nationale Contre le Cancer", International Center for Research in Infectiology, INSERM U1111 - CNRS UMR5308, Ecole Normale Supérieure de Lyon, Université Lyon 1, Lyon, France.
Jocelyn TurpinEquipe Oncogenèse Rétrovirale, Equipe labellisée "Ligue Nationale Contre le Cancer", International Center for Research in Infectiology, INSERM U1111 - CNRS UMR5308, Ecole Normale Supérieure de Lyon, Université Lyon 1, Lyon, France.
Anne CachatEquipe Oncogenèse Rétrovirale, Equipe labellisée "Ligue Nationale Contre le Cancer", International Center for Research in Infectiology, INSERM U1111 - CNRS UMR5308, Ecole Normale Supérieure de Lyon, Université Lyon 1, Lyon, France.
Philippe V AfonsoEpidémiologie et Physiopathologie des Virus Oncogènes, CNRS UMR 3569, Pasteur Institute, Paris, France.
Antoine GessainEpidémiologie et Physiopathologie des Virus Oncogènes, CNRS UMR 3569, Pasteur Institute, Paris, France.
John N BradyVirus Tumor Biology Section, Laboratory of Cellular Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
Cynthia A Pise-MasisonAnimal Models and Retroviral Vaccine Section, Vaccine Branch, CCR, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
Renaud MahieuxEquipe Oncogenèse Rétrovirale, Equipe labellisée "Ligue Nationale Contre le Cancer", International Center for Research in Infectiology, INSERM U1111 - CNRS UMR5308, Ecole Normale Supérieure de Lyon, Université Lyon 1, Lyon, France.
École Normale Supérieure de Lyon · FRCentre National de la Recherche Scientifique · FRInserm · FRInstitut Pasteur · FRLa Ligue Contre le Cancer · FRNational Cancer Institute · USNational Institutes of Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Efficient HTLV-1 viral transmission occurs through cell-to-cell contacts. The Tax viral transcriptional activator protein facilitates this process. Using a comparative transcriptomic analysis, we recently identified a series of genes up-regulated in HTLV-1 Tax expressing T-lymphocytes. We focused our attention towards genes that are important for cytoskeleton dynamic and thus may possibly modulate cell-to-cell contacts. We first demonstrate that Gem, a member of the small GTP-binding proteins within the Ras superfamily, is expressed both at the RNA and protein levels in Tax-expressing cells and in HTLV-1-infected cell lines. Using a series of ChIP assays, we show that Tax recruits CREB and CREB Binding Protein (CBP) onto a c-AMP Responsive Element (CRE) present in the gem promoter. This CRE sequence is required to drive Tax-activated gem transcription. Since Gem is involved in cytoskeleton remodeling, we investigated its role in infected cells motility. We show that Gem co-localizes with F-actin and is involved both in T-cell spontaneous cell migration as well as chemotaxis in the presence of SDF-1/CXCL12. Importantly, gem knock-down in HTLV-1-infected cells decreases cell migration and conjugate formation. Finally, we demonstrate that Gem plays an important role in cell-to-cell viral transmission.

Indexed as

Human T-lymphotropic virus 1Cell LineChemotaxis, LeukocyteChromatin ImmunoprecipitationCytoskeletonFluorescent Antibody TechniqueGene Expression Regulation, ViralGene Products, taxImmunoblottingMonomeric GTP-Binding ProteinsReverse Transcriptase Polymerase Chain ReactionT-LymphocytesTranscriptional ActivationTransduction, GeneticGEM protein, humanGene Products, taxMonomeric GTP-Binding Proteins

Identifiers

PMID24586148
PMCPMC3937318
OpenAlexW2047904179

What Socratic holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.